Company / Capital Returned to Shareholders
IRADIMED CORP Capital Returned to Shareholders History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$15.0M
FY2025
5-year range
$12.6M / $15.0M
FY2021-FY2025
Trend
+10.0%
vs FY2024
Sector context
#86 of 108
Health Care
What the data says
IRADIMED CORP's capital returned to shareholders of $15M is lower than 80% of companies in the Health Care sector (FY2025). Capital Returned to Shareholders has increased for 4 consecutive years, from $10M in FY2018 to $15M in FY2025.
Based on SEC 10-K filings.
$15M in FY2025 with a 3-year CAGR of +6.2%.
Improved from $13M to $15M over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- +6.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
-98.0% below sector average
Key checks
Key Insights
- IRADIMED CORP's capital returned to shareholders has grown for 3 consecutive years.
- 3-year CAGR of +6.2%, indicating consistent growth.
- In FY2025, capital returned to shareholders increased 10.0% year-over-year.
- Ranks #86 out of 108 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 5.29 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.0M | +10.0% |
| FY2024 | $13.7M | +3.4% |
| FY2023 | $13.2M | +5.3% |
| FY2022 | $12.6M | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $10.0M | +0.0% |
| FY2017 | $10.0M | +0.0% |
| FY2016 | $10.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026